|
市場調査レポート
商品コード
1375194
アジア太平洋の医療用マリファナ市場の2028年までの予測-地域別分析：製品タイプ、用途、流通チャネル別Asia Pacific Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and Distribution Channel |
||||||
|
|
|||||||
| アジア太平洋の医療用マリファナ市場の2028年までの予測-地域別分析：製品タイプ、用途、流通チャネル別 |
|
出版日: 2023年08月22日
発行: The Insight Partners
ページ情報: 英文 115 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
アジア太平洋の医療用マリファナ市場は、2022年の21億1,523万米ドルから2028年には62億380万米ドルに成長すると予測されています。2022年から2028年までのCAGRは19.6%と推定されます。
医療用マリファナ市場における地域貿易と連携がアジア太平洋の医療用マリファナ市場の成長を促進
アジアにおける医療用マリファナ市場の今後の展望は、地域貿易の拡大と近隣諸国間の協力的な取り組みが期待されます。この新たな動向は、いくつかの重要な要因に支えられています。第一に、より多くのアジア諸国が医療用大麻の合法化を模索する道に乗り出すにつれ、相互の知識共有やリソースのプールから恩恵を受けるようになり、業界の成長と成熟が促進されます。研究開発、栽培技術、規制の枠組みの調和といった分野での共同事業は、効率性をもたらし、地域全体でより効果的な医療用大麻プログラムを育てることができます。さらに、地域貿易協定は、国境を越えた医療用大麻製品のシームレスな流通を促進することで、市場範囲を拡大し、緊密に連携した業界を育成するのに役立ちます。協力的な取り組みには、品質管理プロトコルの標準化や、患者のアクセスと教育に関するベストプラクティスの交換などが含まれます。
アジア太平洋の医療用マリファナ市場概要
アジア太平洋地域の医療用マリファナ市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。アジア太平洋地域は最も急成長する地域と予想されます。アジア太平洋地域の市場は、医療用大麻に関する調査の増加、大麻産業の勃興、医療用大麻に関連する利点に関する認知度の向上などの要因により、急成長が見込まれています。ただし、同地域では大麻の使用が制限されているため、予測期間中の市場成長は妨げられる可能性があります。
アジア太平洋の医療用大麻市場の収益と2028年までの予測（金額）
アジア太平洋地域の医療用大麻市場のセグメンテーション
アジア太平洋の医療用マリファナ市場は、製品タイプ、用途、流通チャネル、国に区分されます。
製品タイプに基づき、アジア太平洋の医療用マリファナ市場は乾燥形態とエキス形態に区分されます。2022年のアジア太平洋医療用マリファナ市場では、エキス剤が大きなシェアを占めています。
用途別では、アジア太平洋の医療用大麻市場は疼痛管理、トゥレット病、アルツハイマー病、片頭痛、うつ病と不安、多発性硬化症、がん、その他に区分されます。2022年のアジア太平洋医療用マリファナ市場では、疼痛管理分野が最大のシェアを占めています。
流通チャネルに基づき、アジア太平洋の医療用マリファナ市場は小売薬局、eコマース、その他に区分されます。2022年のアジア太平洋医療用マリファナ市場では、小売薬局セグメントが最大のシェアを占めています。
国別では、アジア太平洋医療用マリファナ市場は中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2022年のアジア太平洋医療用マリファナ市場は中国が独占。
Aphria, Inc.、Canopy Growth Corporation、GW Pharmaceuticals、VIVO Cannabis Inc.は、アジア太平洋の医療用マリファナ市場で事業を展開する大手企業です。
目次
第1章 イントロダクション
第2章 アジア太平洋医療用マリファナ市場-要点
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 アジア太平洋医療用マリファナ市場-市場情勢
- アジア太平洋地域-PEST分析
- 専門家の見解
第5章 アジア太平洋地域の医療用マリファナ市場-主要市場力学
- 市場促進要因
- 医療用マリファナ認可の増加
- 市場抑制要因
- 文化的・社会的スティグマ
- 市場機会
- 医療用マリファナの消費者製品市場
- 今後の動向
- 医療用マリファナ市場における地域間取引と連携
- 影響分析
第6章 医療用マリファナ市場：アジア太平洋地域の分析
- アジア太平洋の医療用マリファナ市場の収益予測と分析
第7章 アジア太平洋医療用大麻市場の収益と2028年までの予測-製品別
- 市場概要
- アジア太平洋医療用大麻市場の製品別売上高シェア（2021年、2028年）
- 乾燥形態
- エキス形態
第8章 アジア太平洋医療用マリファナ市場分析-用途別
- アジア太平洋医療用マリファナ市場の用途別売上高シェア（2021年および2028年）
- 疼痛管理
- トゥレット障害
- アルツハイマー病
- 偏頭痛
- うつ病と不安神経症
- 多発性硬化症
- がん
- その他
第9章 アジア太平洋医療用マリファナ市場：流通チャネル別
- アジア太平洋の医療用マリファナ市場：流通チャネル別（2021年・2028年）
- 小売薬局
- eコマース
- その他
第10章 アジア太平洋医療用マリファナ市場の収益と2028年までの予測：国別分析
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他アジア太平洋地域
第11章 アジア太平洋医療用マリファナ市場-業界情勢
- アジア太平洋医療用マリファナ市場における成長戦略（%）
- オーガニック開発
- 無機的展開
第12章 企業プロファイル
- VIVO Cannabis Inc
- Aphria, Inc.
- Canopy Growth Corporation
- GW Pharmaceuticals
第13章 付録
List Of Tables
- Table 1. China: Asia Pacific Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
- Table 2. China: Asia Pacific Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 3. China: Asia Pacific Medical Marijuana Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 4. Japan: Asia Pacific Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
- Table 5. Japan: Asia Pacific Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 6. Japan: Asia Pacific Medical Marijuana Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 7. India: Asia Pacific Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
- Table 8. India: Asia Pacific Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 9. India: Asia Pacific Medical Marijuana Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 10. Australia: Asia Pacific Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
- Table 11. Australia: Asia Pacific Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 12. Australia: Asia Pacific Medical Marijuana Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 13. South Korea: Asia Pacific Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
- Table 14. South Korea: Asia Pacific Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 15. South Korea: Asia Pacific Medical Marijuana Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 16. Rest of Asia Pacific: Asia Pacific Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
- Table 17. Rest of Asia Pacific: Asia Pacific Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million)
- Table 18. Rest of Asia Pacific: Asia Pacific Medical Marijuana Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
- Table 19. Organic Developments in the Asia Pacific Medical Marijuana Market
- Table 20. Inorganic Developments in the Asia Pacific Medical Marijuana Market
- Table 21. Glossary of Terms for Asia Pacific Medical Marijuana Market
List Of Figures
- Figure 1. Asia Pacific Medical Marijuana Market Segmentation
- Figure 2. Asia Pacific Medical Marijuana Market, By Country
- Figure 3. Asia Pacific Medical Marijuana Market Overview
- Figure 4. Extract Form Held Largest Share of Product Segment in Asia Pacific Medical Marijuana Market
- Figure 5. Asia Pacific Region to Show Remarkable Growth During Forecast Period
- Figure 6. Asia Pacific PEST Analysis
- Figure 7. Asia Pacific Medical Marijuana Market- Revenue Forecast and Analysis - 2020- 2028
- Figure 8. Asia Pacific Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
- Figure 9. Dried Form: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 10. Extract Form: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 11. Asia Pacific Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
- Figure 12. Pain Management: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Tourette's: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 14. Alzheimer's Disease: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 15. Migraines: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 16. Depression and Anxiety: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 17. Multiple Sclerosis: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 18. Cancer: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Others: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Asia Pacific Medical Marijuana Market, by Distribution Channel (2021 and 2028)
- Figure 21. Retail Pharmacy: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 22. E-commerce: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 23. Others: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 24. Asia Pacific Medical Marijuana Market, by Key Country - Revenue (2021) (US$ Million)
- Figure 25. Asia Pacific Medical Marijuana Market, by Country, 2021 & 2028 (%)
- Figure 26. China: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 27. Japan: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 28. India: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 29. Australia: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 30. South Korea: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 31. Rest of Asia Pacific: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 32. Growth Strategies in the Asia Pacific Medical Marijuana Market (%)
The Asia Pacific medical marijuana market is expected to grow from US$ 2,115.23 million in 2022 to US$ 6,203.80 million by 2028. It is estimated to register a CAGR of 19.6% from 2022 to 2028.
Regional Trade and Collaboration in the Medical Marijuana Market Fuels Asia Pacific Medical Marijuana Market Growth
The future landscape of the medical marijuana market in Asia holds the promise of increased regional trade and collaborative efforts among neighboring countries. This emerging trend is underpinned by several significant factors. Firstly, as more Asian nations embark on the path of exploring medical marijuana legalization, they stand to benefit from mutual knowledge sharing and resource pooling, expediting the industry's growth and maturation. Collaborative ventures in areas such as research and development, cultivation techniques, and harmonizing regulatory frameworks can yield efficiencies and foster more effective medical cannabis programs across the region. Moreover, regional trade agreements can be instrumental in facilitating the seamless flow of medical marijuana products across borders, thereby expanding the market's reach, and fostering a tightly interlinked industry. Collaborative endeavors may encompass the standardization of quality control protocols and the exchange of best practices pertaining to patients access and education.
Asia Pacific Medical Marijuana Market Overview
The Asia Pacific medical marijuana market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is expected to be the fastest-growing region. The market in Asia Pacific is expected to grow rapidly owing to factors such as increasing research on medical cannabis, the rising cannabis industry, and increasing awareness regarding the benefits associated with medical cannabis. However, restrictions on the use of cannabis in the region may hinder the growth of the market during the forecast period.
Asia Pacific Medical Marijuana Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Medical Marijuana Market Segmentation
The Asia Pacific medical marijuana market is segmented into product type, application, distribution channel, and country.
Based on product type, the Asia Pacific medical marijuana market is segmented into dried form and extract form. The extract form segment held a larger share of the Asia Pacific medical marijuana market in 2022.
Based on application, the Asia Pacific medical marijuana market is segmented into pain management, Tourette's, Alzheimer's disease, migraines, depression and anxiety, multiple sclerosis, cancer, and others. The pain management segment held the largest share of the Asia Pacific medical marijuana market in 2022.
Based on distribution channel, the Asia Pacific medical marijuana market is segmented into retail pharmacy, e-commerce, and others. The retail pharmacy segment held the largest share of the Asia Pacific medical marijuana market in 2022.
Based on country, the Asia Pacific medical marijuana market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific medical marijuana market in 2022.
Aphria, Inc.; Canopy Growth Corporation; GW Pharmaceuticals; and VIVO Cannabis Inc are some of the leading companies operating in the Asia Pacific medical marijuana market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific medical marijuana market .
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific medical marijuana market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Asia Pacific Medical Marijuana Market - by Product
- 1.3.2 Asia Pacific Medical Marijuana Market - by Application
- 1.3.3 Asia Pacific Medical Marijuana Market - by Distribution Channel
- 1.3.4 Asia Pacific Medical Marijuana Market - by Country
2. Asia Pacific Medical Marijuana Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Asia Pacific Medical Marijuana Market - Market Landscape
- 4.1 Overview
- 4.2 Asia Pacific- PEST Analysis
- 4.3 Expert Opinion
5. Asia Pacific Medical Marijuana Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Approvals of Medical Marijuana
- 5.2 Market Restraints
- 5.2.1 Cultural and Social Stigma
- 5.3 Market Opportunities
- 5.3.1 Consumer Product Market for Medical Marijuana:
- 5.4 Future Trends
- 5.4.1 Regional Trade and Collaboration in the Medical Marijuana Market
- 5.5 Impact Analysis
6. Medical Marijuana Market -Asia Pacific Analysis
- 6.1 Asia Pacific Medical Marijuana Market Revenue Forecast and Analysis
7. Asia Pacific Medical Marijuana Market Revenue and Forecast To 2028- by Product
- 7.1 Overview
- 7.2 Asia Pacific Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
- 7.3 Dried Form
- 7.3.1 Overview
- 7.3.2 Dried Form: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Extract Form
- 7.4.1 Overview
- 7.4.2 Extract Form: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Medical Marijuana Market Analysis - by Application
- 8.1 Overview
- 8.2 Asia Pacific Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
- 8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Tourette's
- 8.4.1 Overview
- 8.4.2 Tourette's: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Alzheimer's Disease
- 8.5.1 Overview
- 8.5.2 Alzheimer's Disease: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.6 Migraines
- 8.6.1 Overview
- 8.6.2 Migraines: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.7 Depression and Anxiety
- 8.7.1 Overview
- 8.7.2 Depression and Anxiety: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.8 Multiple Sclerosis
- 8.8.1 Overview
- 8.8.2 Multiple Sclerosis: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.9 Cancer
- 8.9.1 Overview
- 8.9.2 Cancer: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 8.10 Others
- 8.10.1 Overview
- 8.10.2 Others: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Medical Marijuana Market - by Distribution Channel
- 9.1 Overview
- 9.2 Asia Pacific Medical Marijuana Market, by Distribution Channel (2021 and 2028)
- 9.3 Retail Pharmacy
- 9.3.1 Overview
- 9.3.2 Retail Pharmacy: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 E-Commerce
- 9.4.1 Overview
- 9.4.2 E-commerce: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Medical Marijuana Market Revenue and Forecast to 2028 - Country Analysis
- 10.1 Overview
- 10.1.1 Asia Pacific Medical Marijuana Market, by Country, 2021 & 2028 (%)
- 10.1.1.1 China: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 China: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.2 China: Asia Pacific Medical Marijuana Market, by Product, 2019-2028 (US$ Million)
- 10.1.1.1.3 China: Asia Pacific Medical Marijuana Market, by Application, 2019-2028 (US$ Million)
- 10.1.1.1.4 China: Asia Pacific Medical Marijuana Market, by Distribution Channel, 2019-2028 (US$ Million)
- 10.1.1.2 Japan: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Japan: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.2 Japan: Asia Pacific Medical Marijuana Market, by Product, 2019-2028 (US$ Million)
- 10.1.1.2.3 Japan: Asia Pacific Medical Marijuana Market, by Application, 2019-2028 (US$ Million)
- 10.1.1.2.4 Japan: Asia Pacific Medical Marijuana Market, by Distribution Channel, 2019-2028 (US$ Million)
- 10.1.1.3 India: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 India: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.2 India: Asia Pacific Medical Marijuana Market, by Product, 2019-2028 (US$ Million)
- 10.1.1.3.3 India: Asia Pacific Medical Marijuana Market, by Application, 2019-2028 (US$ Million)
- 10.1.1.3.4 India: Asia Pacific Medical Marijuana Market, by Distribution Channel, 2019-2028 (US$ Million)
- 10.1.1.4 Australia: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Australia: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.2 Australia: Asia Pacific Medical Marijuana Market, by Product, 2019-2028 (US$ Million)
- 10.1.1.4.3 Australia: Asia Pacific Medical Marijuana Market, by Application, 2019-2028 (US$ Million)
- 10.1.1.4.4 Australia: Asia Pacific Medical Marijuana Market, by Distribution Channel, 2019-2028 (US$ Million)
- 10.1.1.5 South Korea: Asia Pacific Medical Marijuana Market- Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 South Korea: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.2 South Korea: Asia Pacific Medical Marijuana Market, by Product, 2019-2028 (US$ Million)
- 10.1.1.5.3 South Korea: Asia Pacific Medical Marijuana Market, by Application, 2019-2028 (US$ Million)
- 10.1.1.5.4 South Korea: Asia Pacific Medical Marijuana Market, by Distribution Channel, 2019-2028 (US$ Million)
- 10.1.1.6 Rest of Asia Pacific: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Asia Pacific: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Medical Marijuana Market, by Product, 2019-2028 (US$ Million)
- 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Medical Marijuana Market, by Application, 2019-2028 (US$ Million)
- 10.1.1.6.4 Rest of Asia Pacific: Asia Pacific Medical Marijuana Market, by Distribution Channel, 2019-2028 (US$ Million)
- 10.1.1.1 China: Asia Pacific Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1 Asia Pacific Medical Marijuana Market, by Country, 2021 & 2028 (%)
11. Asia Pacific Medical Marijuana Market - Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Asia Pacific Medical Marijuana Market (%)
- 11.3 Organic Developments
- 11.3.1 Overview
- 11.4 Inorganic Developments
- 11.4.1 Overview
12. Company Profiles
- 12.1 VIVO Cannabis Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Aphria, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Canopy Growth Corporation
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 GW Pharmaceuticals
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms for Asia Pacific Medical Marijuana Market
